ICER Faces New Foe As Patient, Disability Alliance Takes Aims At Reports On Mayzent, Spravato

Groups oppose use of quality-adjusted life year metric, noting ICER’s work is becoming more influential among payers. However, patient advocates do not suggest a uniform methodological alternative.

Jemparingan

More from Market Access

More from Pink Sheet